Sweden In-Vitro Diagnostic Market is predicted to reach USD 910.96 Million by 2030

According to the study by Next Move Strategy Consulting, the Sweden In-Vitro Diagnostics Market size is predicted to reach USD 910.96 million, at a CAGR of 5.0% by 2030.

Request a FREE Sample: https://www.nextmsc.com/sweden-in-vitro-diagnostic-market/request-sample

The increase in healthcare spending in Sweden significantly fuels the growth of the in-vitro diagnostics market.

The advanced medical equipment market of Sweden significantly drives the growth of the IVD market.

The promising players operating in the Sweden in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.